Sarah B. Noonberg Metagenomi, Inc. (MGX) insider trading activity

MGX Quotes by TradingView
Shares Held (Direct Ownership) 109K
4.58% 3M change
8.73% 12M change
Total Value Held N/A

Sarah B. Noonberg Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2025
SELL
Open market or private sale
$9,168 $1.75 p/Share
5,239 Reduced 4.58%
109,135 Common Stock
Apr 01 2025
BUY
Grant, award, or other acquisition
-
14,000 Added 10.91%
114,374 Common Stock
Apr 01 2024
BUY
Grant, award, or other acquisition
-
57,763 Added 36.53%
100,374 Common Stock

Also insider at

PRTA
PROTHENA CORP PUBLIC LTD CO Healthcare
Chief Medical Officer
PTGX
Protagonist Therapeutics, Inc Healthcare
Director
NLTX
Neoleukin Therapeutics, Inc. Healthcare
Director
MRNS
MARINUS PHARMACEUTICALS, INC. Healthcare
SBN

Sarah B. Noonberg

Chief Medical Officer
South San Francisco, CA

Track Institutional and Insider Activities on MGX

Follow Metagenomi, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MGX shares.

Notify only if

Insider Trading

Get notified when an Metagenomi, Inc. insider buys or sells MGX shares.

Notify only if

News

Receive news related to Metagenomi, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MGX